$SDCH
SideChannel, Inc.

2022 Q4 Form 10-K Financial Statement

#000149315222036042 Filed on December 20, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2022
Revenue $1.546M $4.789M $4.789M
YoY Change 23845.0%
Cost Of Revenue $681.0K $2.468M $2.468M
YoY Change
Gross Profit $865.0K $2.321M $2.321M
YoY Change 11505.0%
Gross Profit Margin 55.95% 48.46% 48.47%
Selling, General & Admin $1.337M -$522.7K $1.849M
YoY Change 155.93% -158.77% -31.26%
% of Gross Profit 154.57% -22.52% 79.66%
Research & Development $135.0K -$283.8K $178.0K
YoY Change 4.13% -288.25% -71.29%
% of Gross Profit 15.61% -12.23% 7.67%
Depreciation & Amortization $45.00K $46.00K $46.00K
YoY Change 0.0%
% of Gross Profit 5.2% 1.98% 1.98%
Operating Expenses $1.472M -$806.5K $13.92M
YoY Change 125.75% -177.54% 320.39%
Operating Profit -$607.0K $3.127M -$11.59M
YoY Change -6.91% -400.64% 252.4%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $5.000K $13.00K $13.00K
YoY Change 333.33%
Pretax Income -$602.0K -$8.748M -$11.58M
YoY Change -7.68% 741.05% 273.58%
Income Tax $195.0K $195.0K
% Of Pretax Income
Net Earnings -$602.0K -$8.943M -$11.78M
YoY Change -7.68% 759.79% 279.87%
Net Earnings / Revenue -38.94% -186.76% -245.9%
Basic Earnings Per Share $0.00 -$0.14
Diluted Earnings Per Share $0.00 -$0.12 -$0.14
COMMON SHARES
Basic Shares Outstanding 148.7M shares 148.4M shares 82.00M shares
Diluted Shares Outstanding 148.7M shares 82.00M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.553M $3.030M $3.030M
YoY Change -49.66% -47.61% -47.58%
Cash & Equivalents $2.553M $3.030M $3.030M
Short-Term Investments
Other Short-Term Assets $454.0K $500.0K $500.0K
YoY Change 16.76% 8.74% 8.7%
Inventory
Prepaid Expenses $274.0K $320.0K
Receivables $570.0K $612.0K $612.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.577M $4.142M $4.142M
YoY Change -34.49% -33.66% -33.62%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $1.356M $1.400M
YoY Change
Intangibles $4.940M $4.940M
YoY Change
Long-Term Investments
YoY Change
Other Assets $285.0K $330.0K $330.0K
YoY Change -35.29%
Total Long-Term Assets $6.581M $6.626M $6.626M
YoY Change 1315.27% 1199.22% 1199.22%
TOTAL ASSETS
Total Short-Term Assets $3.577M $4.142M $4.142M
Total Long-Term Assets $6.581M $6.626M $6.626M
Total Assets $10.16M $10.77M $10.77M
YoY Change 71.43% 59.44% 59.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $698.0K $786.0K $786.0K
YoY Change -45.84% -46.26% -46.16%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $50.00K $50.00K $50.00K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.017M $1.161M $1.161M
YoY Change -21.09% -21.96% -22.08%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.017M $1.161M $1.161M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.228M $1.372M $1.372M
YoY Change -4.72% -7.78% -7.92%
SHAREHOLDERS EQUITY
Retained Earnings -$12.54M -$11.93M
YoY Change -83.32%
Common Stock $149.0K $149.0K
YoY Change 54.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.930M $9.396M $9.396M
YoY Change
Total Liabilities & Shareholders Equity $10.16M $10.77M $10.77M
YoY Change 71.43% 59.44% 59.53%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2022
OPERATING ACTIVITIES
Net Income -$602.0K -$8.943M -$11.78M
YoY Change -7.68% 759.79% 279.87%
Depreciation, Depletion And Amortization $45.00K $46.00K $46.00K
YoY Change 0.0%
Cash From Operating Activities -$477.0K $1.799M -$396.0K
YoY Change -33.04% -269.0% -89.09%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions -$3.589M
YoY Change
Other Investing Activities $3.589M $3.589M
YoY Change
Cash From Investing Activities $3.589M $3.589M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -511.0K -$511.0K
YoY Change -106.13%
NET CHANGE
Cash From Operating Activities -$477.0K 1.799M -$396.0K
Cash From Investing Activities 3.589M $3.589M
Cash From Financing Activities -511.0K -$511.0K
Net Change In Cash -$477.0K 4.877M $2.682M
YoY Change -558.15%
FREE CASH FLOW
Cash From Operating Activities -$477.0K $1.799M -$396.0K
Capital Expenditures $0.00
Free Cash Flow -$477.0K -$396.0K
YoY Change -33.04% -89.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
usd
CY2021 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 SDCH Effective Income Tax Rate Reconciliation Nondeductible Expense Contingent Consideration
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseContingentConsideration
pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
pure
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001022505
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
CY2021Q3 us-gaap Goodwill
Goodwill
usd
CY2021Q3 us-gaap Deferred Costs
DeferredCosts
usd
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
usd
CY2021Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
usd
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
CY2021 us-gaap Acquisition Costs
AcquisitionCosts
usd
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2021 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
usd
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
CY2021 SDCH Cash And Cash Equivalents Acquired In Connection With Business Combination
CashAndCashEquivalentsAcquiredInConnectionWithBusinessCombination
usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2021 SDCH Shares Issued For Services Non Cash Investing And Financing Activities
SharesIssuedForServicesNonCashInvestingAndFinancingActivities
usd
CY2021 SDCH Equity Redemption With Note Payable
EquityRedemptionWithNotePayable
usd
CY2021 SDCH Assets Acquired And Liabilities Assumed
AssetsAcquiredAndLiabilitiesAssumed
usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
CY2022Q3 SDCH Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Outstanding Weighted Average Exercise Price Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsOutstandingWeightedAverageExercisePriceExercised
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2021 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-28745
CY2022 dei Entity Registrant Name
EntityRegistrantName
SideChannel, Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-0837077
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
146 Main Street
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 405
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Worcester
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01608
CY2022 dei City Area Code
CityAreaCode
(508)
CY2022 dei Local Phone Number
LocalPhoneNumber
925-0114
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Public Float
EntityPublicFloat
10500000 usd
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
148724056 shares
CY2022 dei Auditor Name
AuditorName
RBSM LLP
CY2022 dei Auditor Location
AuditorLocation
Las Vegas, Nevada
CY2022 dei Auditor Firm
AuditorFirmId
587
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3030000 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
348000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
612000 usd
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
178000 usd
CY2022Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
180000 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
320000 usd
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
306000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
4142000 usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
832000 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
1356000 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4940000 usd
CY2022Q3 us-gaap Deferred Costs
DeferredCosts
330000 usd
CY2022Q3 us-gaap Assets
Assets
10768000 usd
CY2021Q3 us-gaap Assets
Assets
833000 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
786000 usd
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
212000 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
130000 usd
CY2021Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
194000 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
50000 usd
CY2022Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
195000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1161000 usd
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
406000 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
211000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
1372000 usd
CY2021Q3 us-gaap Liabilities
Liabilities
406000 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
100 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
100 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
100 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
100 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
681000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
681000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
148724056 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
148724056 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59900000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59900000 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
149000 usd
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
60000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21180000 usd
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11933000 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
344000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
9396000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
427000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10768000 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
833000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4789000 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2799000 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
2468000 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
1537000 usd
CY2022 us-gaap Gross Profit
GrossProfit
2321000 usd
CY2021 us-gaap Gross Profit
GrossProfit
1262000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1482000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
656000 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
367000 usd
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
96000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
178000 usd
CY2022 us-gaap Acquisition Costs
AcquisitionCosts
6186000 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
5702000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
13915000 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
752000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-11594000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
510000 usd
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
13000 usd
CY2021 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
3000 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13000 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11581000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
513000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
195000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-11776000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
513000 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81997953 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59900000 shares
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
214000 usd
CY2021 SDCH Equity Distributions
EquityDistributions
-210000 usd
CY2021 SDCH Equity Redemptions
EquityRedemptions
-90000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
513000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
427000 usd
CY2022 SDCH Equity Distributions
EquityDistributions
-461000 usd
CY2022 SDCH Equity Redemptions
EquityRedemptions
-100000 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
73000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
6061000 usd
CY2022 SDCH Business Combination Value
BusinessCombinationValue
15172000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-11776000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-11776000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
9396000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-11776000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
513000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
46000 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
73000 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
27000 usd
CY2022 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6061000 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
5702000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
461000 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-15000 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
238000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-18000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-14000 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-65000 usd
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-102000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-396000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
157000 usd
CY2022 SDCH Cash And Cash Equivalents Acquired In Connection With Business Combination
CashAndCashEquivalentsAcquiredInConnectionWithBusinessCombination
3589000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3589000 usd
CY2022 SDCH Equity Redemptions Related To Financing Activies
EquityRedemptionsRelatedToFinancingActivies
50000 usd
CY2021 SDCH Equity Redemptions Related To Financing Activies
EquityRedemptionsRelatedToFinancingActivies
90000 usd
CY2022 SDCH Equity Distributions Related To Financing Activies
EquityDistributionsRelatedToFinancingActivies
461000 usd
CY2021 SDCH Equity Distributions Related To Financing Activies
EquityDistributionsRelatedToFinancingActivies
210000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-511000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-300000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2682000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-143000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
348000 usd
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
491000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3030000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
348000 usd
CY2022 SDCH Shares Issued For Services Non Cash Investing And Financing Activities
SharesIssuedForServicesNonCashInvestingAndFinancingActivities
43000 usd
CY2022 SDCH Equity Redemption With Note Payable
EquityRedemptionWithNotePayable
50000 usd
CY2022 SDCH Assets Acquired And Liabilities Assumed
AssetsAcquiredAndLiabilitiesAssumed
11583000 usd
CY2022Q4 SDCH Potential Annual Revenue
PotentialAnnualRevenue
1300000 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
5700000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
1400000 usd
CY2021Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
194000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_842_eus-gaap--UseOfEstimates_zuluieb3lUQ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zajCkz8Z5ad5">Use of Estimates and Assumptions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities known to exist as of the date the financial statements are published, and (iii) the reported amount of net revenues and expenses recognized during the periods presented. Adjustments made with respect to the use of estimates often relate to improved information not previously available. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of financial statements; accordingly, actual results could differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2022Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2022Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
2800000 usd
CY2022Q3 us-gaap Goodwill Fair Value Disclosure
GoodwillFairValueDisclosure
5700000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
178000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.56
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P4Y4M13D
CY2022Q3 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2021Q3 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2022Q3 SDCH Milestone Revenue
MilestoneRevenue
5500000 usd
CY2022Q3 us-gaap Share Price
SharePrice
0.10
CY2022Q3 SDCH Fair Value Of Closing Shares
FairValueOfClosingShares
6100000 usd
CY2022Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
88400000 usd
CY2022Q3 us-gaap Share Price
SharePrice
0.101
CY2022Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
6200000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100 pure
CY2021 SDCH Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Tax Impact
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRateTaxImpact
-0.2100 pure
CY2022 SDCH Effective Income Tax Rate Reconciliation Nondeductible Expense Contingent Consideration
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseContingentConsideration
-0.0872 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
-0.0814 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.0010 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.0080 pure
CY2022Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
35000000 usd
CY2022 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
4900000 usd
CY2022Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
7000000 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
211000 usd
CY2022 us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
145100000 shares
CY2021 us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
114800000 shares
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.42 pure
CY2021Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.45 pure
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
130000 usd
CY2021Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
194000 usd
CY2021Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
194000 usd
CY2022 SDCH Contract With Customer Liability Deferral Of Revenue
ContractWithCustomerLiabilityDeferralOfRevenue
107000 usd
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
171000 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
130000 usd
CY2020Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
296000 usd
CY2021 SDCH Contract With Customer Liability Deferral Of Revenue
ContractWithCustomerLiabilityDeferralOfRevenue
376000 usd
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
478000 usd
CY2022 us-gaap Payments For Fees
PaymentsForFees
98000 usd
CY2021Q3 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
0 usd
CY2022Q3 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
0 usd
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1000 shares
CY2021Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
100000 usd
CY2022 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
461000 usd
CY2021 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
210000 usd
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
148724056 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59900000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
681000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30000 usd
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8000000.0 shares
CY2021Q3 SDCH Reserve Percentage
ReservePercentage
0.05 pure
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8186106 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8000000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
5561000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
180000 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
8186000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10805000 shares
CY2022Q3 SDCH Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRate
0.073 pure
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.11
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y4M24D
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
427000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.0484 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0129 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000 pure
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
100 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
100 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
100 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
87628920 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.56
CY2022Q3 SDCH Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms One
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsOne
P4Y9M7D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
87628920 shares
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
136000 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
59000 usd
CY2022 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
195000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
195000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
195000 usd
CY2021 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
0 usd
CY2022Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
35600000 usd
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
525000 usd
CY2022 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain stockholders or public groups in the stock of a corporation by more than 50% over a three-year period. Future ownership changes may trigger Section 382 and therefore, substantially limit the amount of pre-Combination NOL’s that can be utilized annually to offset future taxable income.

Files In Submission

Name View Source Status
0001493152-22-036042-index-headers.html Edgar Link pending
0001493152-22-036042-index.html Edgar Link pending
0001493152-22-036042.txt Edgar Link pending
0001493152-22-036042-xbrl.zip Edgar Link pending
ex22-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex4-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
form10-k_htm.xml Edgar Link completed
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sdch-20220930.xsd Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
sdch-20220930_cal.xml Edgar Link unprocessable
sdch-20220930_def.xml Edgar Link unprocessable
sdch-20220930_lab.xml Edgar Link unprocessable
sdch-20220930_pre.xml Edgar Link unprocessable